why choose us

Clinical Trials Search

Showing 7,370 of 132,963 result(s)
A Phase ?b Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)

Status: Completed

Condition: Tumor Infiltrating Lymphocytes

Interventions: Patients with advanced, recurrent or metastatic melanoma (excluding uveal melanoma) who have failed standard treatment such as PD-1 antibodies (if BRA

Date: 2023-11-01

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Status: NOT_YET_RECRUITING

Condition: Tetanus

Interventions: Intramuscular injection, 1 dose of 0.5ml inoculated on Day 0

Date: 2023-11-01

Investigation of a 3 oz Water Protocol on Patients With Tracheostomies

Status: NOT_YET_RECRUITING

Condition: Tracheostomy

Interventions: Patient will consume 3 oz of water continuously without stopping and then will be monitored for one minute post completion.
Patient will complete

Date: 2023-11-01

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Status: Completed

Condition: Healthy

Interventions: Noninvasive pulse oximeter

Date: 2023-11-01

Esomeprazole and Radiation Induced Esophagitis

Status: NOT_YET_RECRUITING

Condition: Radiation Esophagitis

Interventions: Enrolled patients will receive 40 mg of esomeprazole (two pills of 20 mg strength of esomeprazole) once daily before breakfast for the entire duration

Date: 2023-11-01

Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

Status: NOT_YET_RECRUITING

Condition: Candidiasis, Oral

Interventions: Nitric Oxide Releasing Mouthwash will be self-administered by the participant three times throughout the day for 21 days.
The intervention soluti

Date: 2023-11-01

Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy

Status: NOT_YET_RECRUITING

Condition: Cryobiopsy of Peripheral Lymph Nodes

Interventions: Use of 1.1mm ERBE 2 disposable cryoprobe for tissue sampling

Date: 2023-11-01

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Status: Completed

Condition: Cataract

Interventions: Bimatoprost Implant System (High Dose) used in combination with the SpyGlass IOL

Date: 2023-11-01

Strip Meniscometry in Dry Eye Evaluation

Status: COMPLETED

Condition: Dry Eye

Interventions: Measurement of central visual acuity using Snellen optotype chart.

Date: 2023-11-01

Precision Dosing of Metformin in Youth With T2D

Status: NOT_YET_RECRUITING

Condition: Type 2 Diabetes

Interventions: Participants will receive either 2700mg of metformin;day (1350mg twice a day) or 2000mg of metformin;day (1000mg twice a day, standard of ca

Date: 2023-11-01